Avagacestat (BMS-708163)
- CAS No.
- 1146699-66-2
- Chemical Name:
- Avagacestat (BMS-708163)
- Synonyms
- Avagacestat;BMS-708163;CS-262;BMS-708163, >=98%;BMS708163;BMS 708163;Avagacestat (BMS-708163);BMS-708163 (Avagacestat);Avagacestat, 10 mM in DMSO;BMS708163;BMS 708163;AVAGACESTAT;Avagacestat BMS-708163 BMS708163
- CBNumber:
- CB32470907
- Molecular Formula:
- C20H17ClF4N4O4S
- Molecular Weight:
- 520.89
- MDL Number:
- MFCD13195458
- MOL File:
- 1146699-66-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Boiling point | 652.258±65.00 °C(Press: 760.00 Torr)(predicted) |
|---|---|
| Density | 1.488 |
| storage temp. | Store at -20°C |
| solubility | insoluble in H2O; ≥177.6 mg/mL in DMSO; ≥47.6 mg/mL in EtOH with ultrasonic |
| form | Powder |
| pka | 14.970±0.50(predicted) |
| color | White to off-white |
| InChIKey | XEAOPVUAMONVLA-QGZVFWFLSA-N |
| SMILES | NC([C@@H](CCC(F)(F)F)N(S(C1=CC=C(Cl)C=C1)(=O)=O)CC2=C(F)C=C(C3=NOC=N3)C=C2)=O |
| FDA UNII | TQ44WWY45Q |
| UNSPSC Code | 12352200 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H315-H319-H335 | |||||||||
| Precautionary statements | P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P321-P362+P364-P332+P313-P337+P313-P403+P233-P405-P501 | |||||||||
| target organs | Respiratory system | |||||||||
| WGK Germany | WGK 3 | |||||||||
| Storage Class | 11 - Combustible Solids | |||||||||
| Hazard Classifications | Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
|||||||||
| NFPA 704 |
|
Avagacestat (BMS-708163) price More Price(60)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 16711 | Avagacestat ≥98% | 1146699-66-2 | 1mg | $49 | 2026-04-30 | Buy |
| Cayman Chemical | 16711 | Avagacestat ≥98% | 1146699-66-2 | 5mg | $213 | 2026-04-30 | Buy |
| Cayman Chemical | 16711 | Avagacestat ≥98% | 1146699-66-2 | 10mg | $376 | 2026-04-30 | Buy |
| Usbiological | 474079 | BMS 708163 | 1146699-66-2 | 100mg | $2229 | 2026-06-03 | Buy |
| TRC | TRC-C379830-5MG | (R)-2-[[4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide | 1146699-66-2 | 5mg | $193 | 2026-06-03 | Buy |
Avagacestat (BMS-708163) Chemical Properties, Uses, Production
Uses
Avagacestat acts as a γ-secretase inhibitor allowing for treatment of ALzheimer’s disease. On addition it has seen uses targeting embryonic signaling pathways, which control stem cell and cellular development process in cancer therapy.
Definition
ChEBI: Avagacestat is an oxadiazole and a ring assembly.
Biological Activity
bms-708163 is a potent selective and orally bioavailable inhibitor of γ-secretase with ic50 value of 0.3nm [1].the cleavage of amyloid precusor protein app by γ-secretase causes the production of aβ40 and aβ42, which are cytotoxic and cause ad. in vitro assay shows bms-708163 inhibits the formation of aβ40 and aβ42 in h4-8sw cells. it also inhibits the human recombinant cyps in vitro with ic50 value of 20μm. notch receptor is another substrate of γ-secretase. the inhibition of notch signal pathway results in some side effects. it is shown that the activity of bms-708163 to inhibit notch is 190-fold weaker than to app. in female rats, oral administration of bms-708163 significantly reduces the production of aβ in plasma and brain at 10mg/kg and 100mg/kg. in addition, bms-708163 also reduces aβ in brain and csf in male beagle dogs [1].
Synthesis
1146699-70-8
122-51-0
1146699-66-2
Step C. (R)-2-(4-chloro-N-(2-fluoro-4-(N'-hydroxyformamidinyl)benzyl)-benzenesulfonylamino)-5,5,5-trifluoropentanamide (246 g) was added to the reactor, followed by the addition of dry acetonitrile (509 mL), triethyl orthoformate (120 mL) and trifluoroacetic acid (7 mL). The reaction mixture was heated to 40-50 °C and the progress of the reaction was monitored by HPLC until the relative area percentage (AP) of the starting material was below 0.15. Upon completion of the reaction, a one-time addition of methanol (1.48 L) followed by water (1.034 L) was added to maintain the reaction system temperature at 45-50 °C. The reaction mixture was then cooled to 15-20 °C and the solid was collected by filtration. The filter cake was washed with a solvent mixture of acetonitrile:methanol:water (2:6:5, v/v/v) and dried under vacuum at 50-60 °C to afford (2R)-2-[N-[(4-chlorophenyl)sulfonyl]-N-[2-fluoro-4-(1 ,2,4-oxadiazol-3-yl)benzyl]amino]-5,5,5-trifluoropentanamide as a white solid (228 g, 90% yield) . 1H NMR (CDCl3, 300MHz) δ: 1.40-1.58 (m, 1H), 1.75-1.90 (m, 1H), 1.92-2.07 (m, 1H), 2.10-2.26 (m, 1H), 4.37 (dd, J = 8.67, 6.22Hz, 1H), 4.48 (d, J = 15.64Hz, 1H ), 4.64 (d, J = 15.82 Hz, 1H), 5.54 (s, 1H), 6.33 (s, 1H), 7.44-7.54 (m, 2H), 7.62 (t, J = 7.72 Hz, 1H), 7.68-7.76 (m, 3H), 7.85 (dd, J = 7.91, 1.51 Hz, 1H), 8.76 (s, 1H). 1H). 13C NMR (DMSO-d6, 75MHz) δ: 170.34, 167.75, 165.80, 159.64 (d, J = 244.5Hz, 1C), 138.19, 137.64, 131.25 (d, J = 3.75Hz, 1C), 129.31, 129.23, 129.05 (d, J = 14.25 Hz, 1C), 126.74 (q, J = 274.5 Hz, 1C), 126.91, 126.80, 123.12 (d, J = 3.75 Hz, 1C), 113.7 (d, J = 24.0 Hz, 1C), 57.92, 41.38 (d, J = 4.5 Hz, 1C), 30.04 (d, J = 30.0Hz, 1C), 22.90. 19F NMR (CDCl3, 282MHz) δ: -116.3, -66.5. IR (KBr): 3454, 334, 3286, 2952, 1705, 1432, 1325, 1260, 1167, 1084, 828 cm-1. Elemental analysis: Calculated values C20H17ClF4N4O4S: C, 46.11; H, 3.29; N, 10.71; S, 6.15; F, 14.58; Cl, 6.80. Measured values: C, 46.06; H, 3.24; N, 10.71; S, 6.25; F, 14.60; Cl, 6.88.
target
γ-secretase
storage
Store at +4°C
References
[1] gillman kw, starrett je jr, parker mf, xie k, bronson jj, marcin lr, mcelhone ke, bergstrom cp, mate ra, williams r, meredith je jr, burton cr, barten dm, toyn jh, roberts sb, lentz ka, houston jg, zaczek r, albright cf, decicco cp, macor je, olson re. discovery and evaluation of bms-708163, a potent, selective and orally bioavailable γ-secretase inhibitor. acs med chem lett. 2010 mar 22;1(3):120-4.



Avagacestat (BMS-708163) Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2915 | 55 | |
| Chembest Research Laboratories Limited | 021-20908456 | sales@BioChemBest.com | China | 5996 | 61 |
| Jinan Trio PharmaTech Co., Ltd. | 0531-88811783 | sales@trio-pharmatech.com | China | 1856 | 62 |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4765 | 58 |
| NCE Biomedical Co.,Ltd. | 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 | China | 1490 | 55 | |
| China Kouting Group Limited | +86 (21) 5811-6473 5811-6475 | sales@koutingchina.com | China | 494 | 60 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7545 | 61 |
| Shanghai Aladdin Bio-Chem Technology Co.,LTD | 400-6206333 13167063860 | anhua.mao@aladdin-e.com | China | 29977 | 65 |
| Nanjing Dulai Biotechnology Co., Ltd. | 025-84699383-8003;025-846993838003-8003 18013301590 | njduly@126.com | China | 3293 | 55 |
| AdooQ BioScience, LLC | +1 (866) 930-6790 | info@adooq.com | United States | 2774 | 58 |
View Latest Price from Avagacestat (BMS-708163) manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | Avagacestat
1146699-66-2
|
$34.00-125.00 | 99.77% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2023-06-26 | Avagacestat
1146699-66-2
|
$200.00 | 1kg | 99% | 1000kg/Month | Hebei Mingeng Biotechnology Co., Ltd | |
![]() |
2020-01-13 | Avagacestat (BMS-708163)
1146699-66-2
|
$6.68 | 1KG | 97%-99% | 1kg-1000kg | Career Henan Chemical Co |
-

- Avagacestat
1146699-66-2
- $34.00-125.00
- 99.77%
- TargetMol Chemicals Inc.
-

- Avagacestat
1146699-66-2
- $200.00
- 99%
- Hebei Mingeng Biotechnology Co., Ltd
-

- Avagacestat (BMS-708163)
1146699-66-2
- $6.68
- 97%-99%
- Career Henan Chemical Co





